| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $3.96 (Beat by $0.04) |
| EPS GAAP Actual | $3.96 (Beat by $0.04) |
| Revenue Actual | $5.89B |
| Revenue Surprise | Beat by $5890M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $3.76 |
| EPS GAAP Estimate | $3.76 |
| Revenue Estimate | $5.643B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Sep 2030 | 20.67 | 9.79 | 20.39186 | 21.25191 | 1 |
| Sep 2029 | 19.2 | 10.53 | 18.84168 | 19.51782 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.72 | -1.9025 | 5.89B | 7.69% | 533.97M |
| FQ2 2025 (Jun 2025) | 1.99 | -1.67 | 5.509B | 9.42% | 95.2M |
| FQ1 2025 (Mar 2025) | 1.07 | -2.3975 | 5.272B | 4.31% | -46.72M |
| FQ4 2024 (Dec 2024) | 1.05 | -2.83601 | 5.168B | 8.94% | -234.01M |
| FQ3 2024 (Sep 2024) | 1.45 | -1.86693 | 5.437B | 6.44% | 361.13M |
| FQ2 2024 (Jun 2024) | 1.68 | 1.68 | 4.99B | 2.24% | 4990M |
| FQ1 2024 (Mar 2024) | 1.85 | 1.85 | 5.045B | 4.44% | 5045M |
| FQ4 2023 (Dec 2023) | 0.97 | 0.97 | 4.706B | 2.55% | 4706M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
3.76
Consensus Revenue Estimates
5.643B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 4 | -- | 3.91473 | 4.12907 | 5 |
| FQ1 2027 (Mar 2027) | 3.69 | -- | 3.61134 | 3.80907 | 3 |
| FQ4 2026 (Dec 2026) | 3.51 | -- | 3.43517 | 3.62326 | 5 |
| FQ2 2026 (Jun 2026) | 3.95 | 49.62 | 3.95 | 3.95 | 8 |
| FQ1 2026 (Mar 2026) | 3.76 | 71.54 | 3.76 | 3.76 | 8 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2027 (Jun 2027) | 5.97B | -- | 5.87B | 6.12B | 3 |
| FQ1 2027 (Mar 2027) | 5.76B | -- | 5.67B | 5.9B | 3 |
| FQ4 2026 (Dec 2026) | 5.58B | -- | 5.49B | 5.72B | 3 |
| FQ2 2026 (Jun 2026) | 5.67B | 2.86 | 5.67B | 5.67B | 9 |
| FQ1 2026 (Mar 2026) | 5.64B | 6.57 | 5.64B | 5.64B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.6225 | 1.72 | -1.9025 | -110.61% |
| FQ2 2025 (Jun 2025) | 3.66 | 1.99 | -1.67 | -83.92% |
| FQ1 2025 (Mar 2025) | 3.4675 | 1.07 | -2.3975 | -224.07% |
| FQ4 2024 (Dec 2024) | 3.88601 | 1.05 | -2.83601 | -270.1% |
| FQ3 2024 (Sep 2024) | 3.31693 | 1.45 | -1.86693 | -128.75% |
| FQ2 2024 (Jun 2024) | 1.68 | 1.68 | 100% | |
| FQ1 2024 (Mar 2024) | 1.85 | 1.85 | 100% | |
| FQ4 2023 (Dec 2023) | 0.97 | 0.97 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $5.36B | $5.89B | $533.97M | 9.07% |
| FQ2 2025 (Jun 2025) | $5.41B | $5.51B | $95.2M | 1.73% |
| FQ1 2025 (Mar 2025) | $5.32B | $5.27B | $-46.72M | -0.89% |
| FQ4 2024 (Dec 2024) | $5.4B | $5.17B | $-234.01M | -4.53% |
| FQ3 2024 (Sep 2024) | $5.08B | $5.44B | $361.13M | 6.64% |
| FQ2 2024 (Jun 2024) | $0B | $4.99B | $4990M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $5.05B | $5045M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $4.71B | $4706M | 100% |